Because we had access to only one tumor-antigen-specific CD8+ T cell clone, we could not examine whether the radiation-mediated enhancement of cancer cell recognition through MHC I-presented antigens occurred for antigens other than NY-ESO-1. The gene discussed is CD8A; the disease is neoplasm.